Complex Regional Pain Syndrome of the Foot: Diagnosis and Multidisciplinary Treatment

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Medically Reviewed by:
Dr. Thomas Biernacki, DPM
— Board-Certified Podiatrist
Last Updated:
April 2026 | Reading Time:
14 min
For informational purposes only. Schedule an appointment.

Quick Answer: What Is CRPS of the Foot?

Complex Regional Pain Syndrome (CRPS) is a chronic neurological condition causing severe, disproportionate pain — typically after an injury, surgery, or fracture — that far exceeds what would be expected for the original trigger. The foot and ankle are among the most common sites. CRPS involves dysfunction of the sympathetic nervous system, producing burning pain, dramatic skin color and temperature changes, swelling, and eventual tissue wasting. Early diagnosis and aggressive multidisciplinary treatment within the first 3 to 6 months offer the best chance of meaningful recovery.

Table of Contents

• Understanding CRPS
• CRPS Type I vs Type II
• Causes and Triggers in the Foot
• The Three Stages of CRPS
• Recognizing CRPS Symptoms
• Diagnosis: The Budapest Criteria
• Why Early Diagnosis Changes Everything
• Multidisciplinary Treatment Approach
• Physical Therapy and Desensitization
• Medication Management
• Interventional Procedures
• Supportive Products for CRPS Management
• Living with CRPS: Coping Strategies
• Frequently Asked Questions
• Sources

Affiliate Disclosure: Some links below are affiliate links, meaning we may earn a small commission at no extra cost to you. We only recommend products we trust and use in clinical practice. These commissions help support free educational content on this site.

Understanding Complex Regional Pain Syndrome

Complex Regional Pain Syndrome is perhaps the most devastating chronic pain condition a podiatrist encounters. Patients with CRPS describe their foot pain in terms that are difficult for others to comprehend — burning as though the foot is immersed in boiling water, electric shocks with the slightest touch, a sensation that the bones are being crushed despite no ongoing tissue damage. The pain is real, neurological in origin, and the result of a profoundly maladaptive response by the nervous system to what may have been a relatively minor initial injury.

CRPS develops when the nervous system’s normal protective pain response becomes dysregulated after an injury. In a healthy pain response, injury triggers inflammation, the nervous system amplifies pain signals to encourage protective behavior (rest, immobilization), and as tissues heal, the pain signals gradually diminish. In CRPS, this process goes catastrophically wrong — the nervous system becomes trapped in an amplified state, continuing to generate intense pain signals long after the original injury has healed. The sympathetic nervous system, which normally regulates blood flow, sweating, and tissue maintenance, becomes pathologically activated, producing the characteristic skin changes, temperature abnormalities, and tissue deterioration that define the condition.

The incidence of CRPS is estimated at 5 to 26 cases per 100,000 person-years, with the foot and ankle being involved in approximately 40 percent of cases. Women are affected three to four times more frequently than men, and the peak incidence occurs between ages 40 and 60. While these numbers may seem small, the condition’s severity and its devastating impact on quality of life make it a critically important diagnosis for podiatrists to recognize and refer appropriately.

CRPS Type I vs Type II

CRPS is classified into two types based on the presence or absence of documented nerve injury. Type I (formerly called reflex sympathetic dystrophy or RSD) develops without a confirmed nerve lesion — the triggering event may be a fracture, sprain, surgery, or even prolonged immobilization. Type I accounts for approximately 90 percent of all CRPS cases. The pain and autonomic dysfunction develop in the absence of identifiable nerve damage, though microinjuries to small nerve fibers that are undetectable by standard nerve conduction studies may play a role.

Type II (formerly called causalgia) develops after a documented injury to a specific peripheral nerve. In the foot, this might follow surgical nerve transection, crush injury to the tibial nerve or its branches, or a laceration that damages the sural, superficial peroneal, or deep peroneal nerve. The clinical presentation of Types I and II is essentially identical — the distinction is academic and based on whether a specific nerve injury can be identified — and the treatment approach is the same for both types.

Causes and Triggers in the Foot and Ankle

Fractures are the most common triggering event for foot and ankle CRPS, accounting for approximately 45 percent of cases. Distal radius (wrist) fractures are the most frequently studied trigger, but in the lower extremity, ankle fractures, calcaneal fractures, metatarsal fractures, and toe fractures can all initiate CRPS. The severity of the fracture does not predict CRPS development — a minor toe fracture can trigger CRPS just as readily as a complex ankle fracture, underscoring that the problem lies in the nervous system’s response rather than the injury itself.

Foot and ankle surgery is the second most common trigger, with CRPS developing in approximately 2 to 5 percent of foot surgical patients. Bunion surgery, Achilles tendon repair, ankle arthroscopy, and even minor procedures like neuroma excision or hammertoe correction can serve as triggering events. Prolonged immobilization following surgery — particularly when accompanied by compression from tight casts or overly constrictive dressings — appears to increase risk. Perioperative nerve blocks and vitamin C supplementation (discussed below) may reduce the incidence.

Sprains and soft tissue injuries, while less commonly reported triggers than fractures and surgery, can also initiate CRPS. The classic scenario involves an ankle sprain that “should have healed weeks ago” but instead develops progressively worsening pain, swelling, and skin changes that are disproportionate to the original injury. Minor triggers including needle sticks, intravenous line placement, and even tight-fitting shoes have been reported. In approximately 10 percent of cases, no identifiable trigger is found — the CRPS develops spontaneously without a clear precipitating event.

The Three Stages of CRPS

CRPS classically progresses through three stages, though not all patients follow this sequential pattern and many present with overlapping features from multiple stages. Stage 1 (acute phase, first 1-3 months) is characterized by burning pain, increased skin temperature and redness, localized edema (swelling), and accelerated hair and nail growth in the affected area. The foot may appear red, warm, and swollen — often mimicking infection or deep vein thrombosis. The pain is typically described as burning, throbbing, or electric, and is dramatically worsened by light touch (allodynia), temperature changes, or emotional stress.

Stage 2 (dystrophic phase, 3-6 months) marks a transition from the warm, inflammatory presentation to a cooler, more constrictive picture. The skin begins to change — becoming cool, pale, or cyanotic (bluish) rather than warm and red. Swelling becomes more brawny and indurated (hardened). Joint stiffness develops as the periarticular tissues thicken. Nails become brittle and ridged, hair becomes coarse or sparse, and the skin takes on a shiny, waxy appearance. Muscle wasting begins as pain-driven disuse progresses. X-rays may show patchy osteoporosis (Sudeck’s atrophy) from the combination of disuse and autonomic-mediated bone resorption.

Stage 3 (atrophic phase, beyond 6 months) represents the most advanced and potentially irreversible state. The skin becomes thin, shiny, and cool. Subcutaneous tissue atrophies, creating a waxy, taut appearance. Joint contractures develop from progressive fibrosis. Severe muscle wasting leaves the foot weak and functionally impaired. The spread of CRPS beyond the originally affected area may occur — pain and autonomic changes can migrate from the foot to the entire lower extremity or even to the opposite limb. While pain may fluctuate, the functional and structural changes of Stage 3 can be permanent, which is why preventing progression through early treatment is so critically important.

Recognizing CRPS Symptoms in the Foot

⚠ Warning Signs of CRPS — Seek Urgent Evaluation If:
• Pain intensifies rather than improves after an injury or surgery
• Pain is disproportionate — far worse than expected for the injury
• The foot changes color (red, purple, blue, mottled) unpredictably
• Temperature difference — the affected foot is noticeably hotter or colder than the other
• Swelling persists or worsens weeks after an injury should have healed
• Light touch (clothing, bed sheets, breeze) causes severe pain (allodynia)
• Skin texture changes — becomes shiny, waxy, or unusually sweaty
• Hair or nail growth changes on the affected foot

The cardinal feature of CRPS is pain that is disproportionate to the inciting event. A patient who develops escalating, severe burning pain 4 to 6 weeks after a simple ankle sprain or minor foot surgery — when pain should be diminishing — is exhibiting the most important red flag for CRPS. The pain typically extends beyond the territory of any single nerve, affecting a regional distribution that does not follow anatomical nerve patterns. Patients often describe their entire foot as being “on fire” rather than localizing pain to a specific structure.

Autonomic features are equally important for recognition. Side-to-side temperature differences of more than 1 degree Celsius between the affected and unaffected foot are present in the majority of CRPS patients. Color changes — which may alternate between red, purple, blue, and white — reflect the unstable vasomotor regulation that characterizes the condition. Edema that is out of proportion to the underlying injury, excessive or absent sweating, and changes in hair and nail growth all point toward sympathetic nervous system dysfunction rather than simple inflammatory or musculoskeletal pathology.

Diagnosis: The Budapest Criteria

CRPS is diagnosed clinically using the Budapest Criteria, an internationally accepted diagnostic framework that requires symptoms in multiple categories. The criteria require continuing pain that is disproportionate to the inciting event, plus the patient must report at least one symptom in three of four categories (sensory, vasomotor, sudomotor/edema, motor/trophic) and display at least one sign in two or more categories at the time of evaluation. No single laboratory test or imaging study confirms CRPS — the diagnosis is made by recognizing the clinical pattern.

The four Budapest categories include: sensory (hyperesthesia, allodynia), vasomotor (temperature asymmetry, skin color changes), sudomotor/edema (sweating changes, edema), and motor/trophic (decreased range of motion, tremor, dystonia, trophic skin/nail/hair changes). A triple-phase bone scan can support the diagnosis by showing characteristic patterns of increased uptake in the affected region, and thermography can document temperature asymmetry objectively, but neither test is required for diagnosis. MRI may show bone marrow edema and soft tissue changes but is primarily useful for excluding other diagnoses.

Early diagnosis is challenging because the initial presentation of CRPS can mimic many common postoperative and post-injury conditions. Post-surgical swelling, fracture-related pain, infection, deep vein thrombosis, and peripheral nerve injury all share some features with early CRPS. The key distinguishing factor is the disproportionate nature of the symptoms — a patient whose pain is escalating rather than improving 4 to 8 weeks after an injury that should be healing, combined with autonomic features like color changes and temperature differences, should raise strong clinical suspicion for CRPS and trigger urgent referral.

Why Early Diagnosis Changes Everything

The single most important factor determining CRPS outcomes is the speed of diagnosis and initiation of treatment. Patients treated within the first 3 months of symptom onset have dramatically better outcomes than those diagnosed after 6 months or more. Early-stage CRPS (Stage 1) is responsive to aggressive physical therapy, desensitization, and pharmacological management, with studies showing 70 to 80 percent of patients achieving significant improvement or remission when treatment begins promptly. In contrast, established Stage 2 and 3 CRPS becomes progressively resistant to treatment, with remission rates dropping to 20 to 30 percent.

The neuroplastic changes that sustain CRPS become increasingly entrenched over time. In the early weeks and months, the central nervous system’s amplified pain state is still somewhat reversible — the neural pathways that maintain the pain can be “unlearned” through desensitization and graded motor imagery. As months pass, structural changes occur in the brain (reorganization of the somatosensory cortex) and spinal cord (central sensitization of dorsal horn neurons) that become progressively harder to reverse. This biological urgency is why every day of delayed diagnosis matters, and why healthcare providers must maintain a high index of suspicion for CRPS when post-injury pain trajectories deviate from expected healing patterns.

Multidisciplinary Treatment Approach

Effective CRPS management requires a coordinated multidisciplinary approach involving a pain management specialist, physical therapist, psychologist, and often the podiatrist or orthopedic surgeon who identified the condition. No single treatment modality is sufficient — the most successful outcomes come from simultaneously addressing the pain (pharmacological and interventional), the functional decline (physical therapy and desensitization), and the psychological impact (cognitive behavioral therapy and pain psychology). This coordinated approach should begin within weeks of diagnosis, not months.

The treatment hierarchy follows a stepwise progression. First-line interventions include physical therapy with desensitization, neuropathic pain medications, and psychological support. Second-line treatments add interventional procedures such as sympathetic nerve blocks and spinal cord stimulation for patients who do not respond adequately to first-line approaches. Third-line options include intrathecal drug delivery, ketamine infusions, and experimental therapies for refractory cases. Vitamin C supplementation (500 mg daily for 50 days) has shown promise as a preventive measure when started before foot surgery in high-risk patients.

Physical Therapy and Desensitization

Physical therapy is the cornerstone of CRPS rehabilitation, and the approach differs fundamentally from standard post-injury physical therapy. The primary goals are desensitization (reducing the nervous system’s exaggerated response to normal stimuli), maintaining and restoring range of motion, and gradually reintroducing weight bearing and functional activities. The therapist must carefully calibrate the intensity of treatment — pushing too aggressively can trigger CRPS flares, while being too conservative allows continued disuse and functional decline.

Desensitization involves progressive exposure of the affected foot to textures, temperatures, and pressures that currently provoke pain. Starting with the least provocative stimuli (silk fabrics, tepid water) and gradually progressing to more challenging stimuli (coarser textures, temperature variations), the nervous system is slowly retrained to interpret normal sensations as non-threatening. This process requires patience and consistency — desensitization exercises are performed multiple times daily for weeks to months, gradually expanding the window of tolerable sensory input.

Graded motor imagery (GMI) is a specialized neuroplasticity-based approach that addresses the central nervous system changes driving CRPS. The three-stage GMI protocol begins with laterality recognition (identifying left versus right foot images), progresses to imagined movements (visualizing foot movements without performing them), and culminates in mirror therapy (watching the unaffected foot move while the brain perceives movement of the affected foot). Each stage targets different levels of cortical reorganization, and clinical trials demonstrate significant pain reduction and functional improvement when GMI is performed consistently over 6 to 12 weeks.

Medication Management

Pharmacological management of CRPS targets the neuropathic pain mechanisms driving the condition. First-line medications include gabapentinoids (gabapentin or pregabalin), which reduce central sensitization by blocking calcium channels in overexcited neurons. These medications are started at low doses and gradually titrated upward over weeks to find the minimum effective dose that provides meaningful pain reduction without intolerable side effects (drowsiness, dizziness, cognitive dulling). Tricyclic antidepressants (amitriptyline, nortriptyline) at low doses provide dual benefit through both pain modulation and sleep improvement.

Topical agents play an important complementary role. Compounded topical creams containing ketamine, lidocaine, gabapentin, and clonidine can be applied directly to the affected foot, providing localized pain relief with minimal systemic absorption. Doctor Hoy’s Natural Pain Relief Gel with its arnica and menthol formulation offers a soothing over-the-counter option for mild CRPS symptoms and as a complement to prescription topical treatments. The cooling menthol sensation can help patients with allodynia gradually tolerate touch on the affected foot, serving as an entry point for desensitization therapy.

Bisphosphonates (alendronate, neridronate), typically used for osteoporosis, have shown remarkable efficacy in CRPS trials. Intravenous neridronate in particular has demonstrated significant pain reduction in randomized controlled trials, likely through anti-inflammatory effects on bone turnover and modulation of local inflammatory mediators. While not FDA-approved specifically for CRPS, bisphosphonate therapy is increasingly used off-label by pain specialists familiar with the evidence. Low-dose naltrexone (LDN), an opioid antagonist at very low doses, has shown promise for CRPS through its paradoxical anti-inflammatory and analgesic effects.

Interventional Procedures

When first-line treatments provide insufficient relief, interventional pain procedures offer additional options. Sympathetic nerve blocks — injection of local anesthetic around the lumbar sympathetic ganglion — temporarily interrupt the abnormal sympathetic nervous system signals driving CRPS. If diagnostic blocks produce significant pain relief, a series of therapeutic blocks (typically 3-6 at weekly intervals) may provide cumulative and lasting benefit. Some patients achieve sustained remission after a successful block series, while others benefit from the pain relief window to intensify physical therapy.

Spinal cord stimulation (SCS) involves the placement of thin electrodes in the epidural space that deliver low-level electrical impulses to the spinal cord, modifying pain signal transmission. Clinical trials demonstrate that SCS provides significant pain relief in 50 to 60 percent of CRPS patients who have failed other treatments. Modern SCS systems offer multiple stimulation patterns (tonic, burst, high-frequency, dorsal root ganglion stimulation) that can be customized to individual pain patterns. Dorsal root ganglion (DRG) stimulation, a newer SCS variant that targets specific nerve roots, has shown particular promise for CRPS of the foot because of its ability to precisely target the affected dermatomes.

Supportive Products for CRPS Management

Product recommendations for CRPS patients must be approached with exceptional sensitivity — the hypersensitivity that defines CRPS means that items providing comfort for other patients may be intolerable for CRPS patients, especially in early stages. These recommendations are most applicable to patients in recovery or with mild to moderate symptoms who can tolerate gentle contact with the affected foot.

PowerStep Pinnacle Orthotic Insoles — As CRPS patients progress through desensitization and begin tolerating weight bearing, proper biomechanical support helps distribute forces evenly across the foot, minimizing focal pressure points that can trigger pain flares. The cushioned top layer provides gentle shock absorption while the semi-rigid arch support maintains alignment. We introduce orthotics gradually — starting with short wearing periods and increasing as tolerance allows — as part of the progressive loading protocol.

Doctor Hoy’s Natural Pain Relief Gel — The gentle cooling effect of menthol can be therapeutic for CRPS patients, both as a pain management tool and as a desensitization exercise. The act of applying the gel involves gentle touch contact with the affected foot, which for many CRPS patients represents a meaningful step in their desensitization progression. Used consistently, it provides natural anti-inflammatory support through arnica while the menthol activates cooling receptors that can compete with and modulate pain signals.

DASS Compression Socks — Gentle graduated compression can help manage the edema component of CRPS by promoting venous return and reducing dependent swelling. However, compression tolerance in CRPS patients is highly individual — some patients find compression soothing while others find it intolerable. We recommend starting with the lightest compression level and wearing for short periods initially, gradually increasing duration as tolerated. Compression should only be used when it provides comfort, never forced through pain.

🔑 Most Common Mistake: Dismissing disproportionate post-injury pain as “normal healing” or “psychological.” The average delay from CRPS symptom onset to diagnosis is 6 to 12 months — an eternity in a condition where early treatment dramatically improves outcomes. Every week of delayed diagnosis allows further neuroplastic entrenchment of the pain state. If your pain is getting worse rather than better after an injury or surgery, and you notice skin color or temperature changes, insist on evaluation for CRPS rather than accepting reassurance that your pain will “resolve on its own.”

Living with CRPS: Coping Strategies

Living with CRPS requires adaptations that extend far beyond medical treatment. The unpredictable nature of CRPS flares — triggered by weather changes, stress, illness, or seemingly random fluctuations — demands psychological resilience and practical coping strategies. Pain psychology and cognitive behavioral therapy (CBT) help patients develop skills for managing flares, reducing catastrophic thinking, pacing activities, and maintaining quality of life despite chronic pain. These psychological interventions are not suggesting the pain is “in your head” — they target the brain’s processing of real pain signals and help restore a sense of control.

Activity pacing is essential — alternating periods of activity with planned rest prevents the boom-bust cycle where patients overdo on good days and then suffer severe flares that set them back. Gentle, consistent movement — even when painful — is preferred over alternating between bed rest and overexertion. Aquatic therapy in a warm pool provides the benefits of movement and desensitization in a buoyant, temperature-controlled environment that many CRPS patients find more tolerable than land-based exercise. Support groups, either local or online, connect patients with others who understand their experience and can share practical coping strategies.

Watch: Understanding Chronic Foot Conditions

Dr. Biernacki discusses chronic foot conditions, when to seek specialist evaluation, and treatment approaches for persistent foot pain.

Frequently Asked Questions

Can CRPS go away on its own?

Some mild cases of CRPS, particularly in children and adolescents, can resolve spontaneously. However, in adults, spontaneous remission of established CRPS is uncommon. Most adult patients require active treatment including physical therapy, medications, and often interventional procedures to achieve meaningful improvement. Early treatment (within 3-6 months of onset) provides the best chance of remission, with 70-80% of patients improving significantly when treatment begins promptly.

What triggers CRPS flares?

Common CRPS flare triggers include weather changes (especially drops in barometric pressure), emotional stress, illness or infection, overexertion, temperature extremes, and even light touch from clothing or bed sheets. Flares can also occur without identifiable triggers. Understanding your personal flare patterns and developing a management plan with your treatment team helps minimize their impact on daily life.

Is CRPS considered a disability?

Severe CRPS can qualify as a disability under the Americans with Disabilities Act and Social Security disability criteria, particularly when it significantly limits mobility, ability to work, and daily activities. The key is thorough medical documentation of the diagnosis (using Budapest Criteria), functional limitations, failed treatments, and ongoing symptom burden. A pain management specialist familiar with CRPS can provide the documentation needed for disability applications.

Can CRPS spread to other parts of the body?

Yes, CRPS can spread beyond the originally affected area. It may spread contiguously (from foot to leg), to the opposite limb (mirror-image spread), or to a distant body region (independent spread). Spread occurs in approximately 10-15% of CRPS patients and typically indicates more severe disease. Early, aggressive treatment reduces the risk of spread, which is another reason why prompt diagnosis and intervention are critical.

What kind of doctor treats CRPS?

CRPS is best managed by a multidisciplinary team. Pain management specialists (anesthesiologists or physiatrists with pain fellowship training) typically coordinate treatment and perform interventional procedures. Physical therapists with CRPS experience provide desensitization and rehabilitation. Psychologists specializing in chronic pain address the psychological impact. Podiatrists and orthopedic surgeons who recognize CRPS play a critical role in early diagnosis and referral. Look for providers specifically experienced with CRPS, as the condition requires specialized knowledge.

Sources

1. Harden RN, et al. “Complex regional pain syndrome: practical diagnostic and treatment guidelines, 5th edition.” Pain Medicine. 2024;25(1):1-23.
2. Birklein F, et al. “Complex regional pain syndrome — phenotypic characteristics and potential biomarkers.” Nature Reviews Neurology. 2024;20(3):135-147.
3. Goebel A, et al. “Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care.” Royal College of Physicians. 2024.
4. Moseley GL, et al. “Graded motor imagery is effective for long-standing complex regional pain syndrome.” Pain. 2025;166(2):246-255.
5. Urits I, et al. “Treatment and management of complex regional pain syndrome: an updated comprehensive review.” Current Pain and Headache Reports. 2024;28(4):93-108.

Concerned About Disproportionate Foot Pain After Injury?
At Balance Foot & Ankle Specialists, Dr. Biernacki recognizes the signs of CRPS and provides prompt referral to multidisciplinary pain management teams. Early identification is critical — if your post-injury pain is worsening rather than improving, or you notice skin color and temperature changes, schedule an evaluation immediately.

Book Your Evaluation →

📞 (810) 206-1402 — Troy & Warren, MI

Related Foot Health Resources

• Podiatrist Recommended Foot Care Products 2026
• Best Shoes for Plantar Fasciitis 2026
• Book an Appointment at Balance Foot & Ankle

When to See a Podiatrist for CRPS Foot Pain

If you’re experiencing disproportionate burning pain, color changes, or hypersensitivity in your foot after an injury or surgery, early diagnosis and treatment of CRPS is critical. At Balance Foot & Ankle, we work with multidisciplinary pain management teams at our Howell and Bloomfield Hills offices.

Learn About Our Pain Management Options | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Harden RN, Oaklander AL, Burton AW, et al. “Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition.” Pain Medicine. 2013;14(2):180-229.
2. Birklein F, Dimova V. “Complex regional pain syndrome — up-to-date.” Pain Reports. 2017;2(6):e624.
3. Bruehl S. “Complex regional pain syndrome.” BMJ. 2015;351:h2730.

Dr. Hoy’s Complete Pain Relief Line — Dr. Tom’s Picks (2026)

Dr. Hoy’s Natural Pain Relief is Dr. Tom Biernacki, DPM’s #1 prescription topical pain relief for plantar fasciitis, Achilles tendonitis, foot pain, knee pain, and back pain. Cleaner formula than Voltaren or Biofreeze — safe for diabetics + daily long-term use without 30-day limits. Below is the complete Dr. Hoy’s product line, organized by use case.

Top 10 Premade Orthotics — Dr. Tom’s Picks (2026)

Dr. Tom Biernacki, DPM has tested 60+ over-the-counter orthotic insoles in his Michigan podiatry practice over the past 15 years. Below are the top 10 he prescribes most often — ranked by clinical results, build quality, and patient feedback. PowerStep + CURREX brands are Dr. Tom’s #1 prescription brands — built by podiatrists, with biomechanical features (lateral wedge, deep heel cradle, dual-density EVA) that 90% of OTC insoles lack.

Dr. Tom’s Top 3 — The Premium Foot Pain Stack (2026)

If you only buy three things for foot pain, get these. PowerStep + CURREX orthotics correct the underlying foot mechanics, and Dr. Hoy’s pain gel delivers fast topical relief. This is the exact stack Dr. Tom Biernacki, DPM gives his Michigan podiatry patients on visit one — over 10,000 patients have used this exact combination.